Toggle light / dark theme

Announcement of CRISPR technology, which allows precise editing of the human genome, has been heralded as the future of individualized medicine, and a decried as a slippery slope to engineering individual human qualities. Of course, humans already know how to manipulate animal genomes through selective breeding, but there has been no appetite to try on humans what is the norm for dogs. That’s a good thing, says Dawkins. The results could well be dangerous. Does technology as a whole represent a threat to human welfare if it continues to evolve at its current rate? Not so fast, warns Dawkins. Comparing biological evolution to technological progress is an analogy at best. His newest book is Science in the Soul: Selected Writings of a Passionate Rationalist.

Follow Big Think here:
YouTube: http://goo.gl/CPTsV5
Facebook: https://www.facebook.com/BigThinkdotcom
Twitter: https://twitter.com/bigthink

Transcript: I think it’s — I’m a believer in the precautionary principle as I’ve just said, and I think we have to worry about possible consequences of things that we do, and the ability to edit our own genomes is one thing we ought to worry about. I’m not sure it’s so much an ethical problem as a more practical problem. What would the consequences be? Would the consequences be bad? And they might be.

I think it’s worth noticing that long before CRISPR long before it became capable of editing our genomes in anyway we have been editing the genomes of domestic animals and plants by artificial selection, not artificial mutation, which is what we’re now talking about, but artificial selection. When you think that a Pekingese is a wolf, a modified wolf, a genetically modified wolf—modified not by directly manipulating genes but by choosing for breeding individuals who have certain characteristics, for example, a small stubbed nose, et cetera, and making a wolf turn into a Pekingese. And we’ve been doing that very successfully with domestic animals like dogs, cows, domestic plants like maize for a long time, we’ve never done that to humans or hardly at all.

Hitler tried it but it’s never really been properly done with humans I’m glad to say. So if we’ve never done that with humans with the easy way, which is artificial selection, it’s not obvious why we would suddenly start doing it the difficult way, which is by direct genetic manipulation. There doesn’t seem to be any great eagerness to do it over the last few centuries anyway.

A lot of people have problems with what they call designer babies. You could imagine a future scenario in which people go to a doctor and say, “Doctor, we want our baby to be a musical genius. Please edit the genes so that we have the same genes as the Bach family had or something like that to make them into a musical genius.” I mean that horrifies many people.

A Stanford team has launched a new challenge on the Eterna computer game. Players will design a CRISPR-controlling molecule, and with it open the possibility of new research and therapies.

A team of researchers at the Stanford University School of Medicine has launched a new challenge for the online computer game Eterna in which players are being asked to design an RNA molecule capable of acting as an on/off switch for the gene-editing tool CRISPR/Cas9.

Molecular biologists will then build and test the actual molecules, based on the most promising designs provided by the players.

Read more

It is important to note that none of the embryos were allowed to develop for more than a few days, and that the team never had any intention of implanting them into a womb. However, it seems that this is largely due to ongoing regulatory issues, as opposed to issues with the technology itself.

In the United States, all efforts to turn edited embryos into a baby — to bring the embryo to full term — have been blocked by Congress, which added language to the Department of Health and Human Services funding bill that forbids it from approving any such clinical trials.

Related: CRISPR-CAS9: The Future of Genetic Engineering (Infographic)

Read more

A Chicagoland hospital system has added something new to its patients’ annual checkups: the option to get a genetic test.

Until now, DNA tests have tended to live either in the consumer realm or through referrals to specialists when a patient brings it up.

NorthShore University HealthSystem wants to bring that conversation about genetics into every doctor’s office during annual checkups.

Read more

Scientists recently used a gene-editing tool to fix a mutation in a human embryo. Around the world, researchers are chasing cures for other genetic diseases.

Now that the gene-editing genie is out of the bottle, what would you wish for first?

Babies with “perfect” eyes, over-the-top intelligence, and a touch of movie star charisma?

Read more

“If astronauts are going to make journeys that span several years, we’ll need to find a way to reuse and recycle everything they bring with them,” says Mark A. Blenner, assistant professor of chemical and biomolecular engineering at Clemson University, South Carolina.

To this end, the Blenner Research Group is looking into the potential uses of a type of yeast called Yarrowia lipolytica, that feeds on the urea content of urine.

With a little genetic engineering the group has proven that the yeast can be used to produce hydrogen and carbon – the atomic ingredients of nutrients like Omega 3, and polyester-based 3D printer filament.

Read more

China’s five year plan to eliminate birth defects by preimplantation genetic diagnosis of embryos.

Gene-editing with CRISPR has been in the headlines over the past month and touted as a way of eliminating genetic diseases. But the cruder and cheaper technique of preimplantation genetic diagnosis does the same. And it is exploding in China. According to a feature in Nature, fertility doctors there “have been pursuing a more aggressive, comprehensive and systematic path towards its use there than anywhere else”.

The government’s current five-year plan for economic development has made reproductive medicine, including PGD, a priority. In 2004, only four clinics in the whole country were licensed to perform PGD; now there are 40.


Very little ethical push-back exists.

Read more

By Aylin Woodward

Injections of vitamin C could be a way to help fight blood cancer. Experiments in mice suggest that the nutrient helps tell out-of-control cells to stop dividing and die.

Some blood cancers, including acute and chronic leukaemia, often involve mutations affecting a gene called TET2. This gene usually helps ensure that a type of stem cell matures properly to make white blood cells, and then eventually dies. But when TET2 mutates, these cells can start dividing uncontrollably, leading to cancer. Mutations in TET2 are involved in around 42,500 cancers in the US a year.

Read more